CYP2A6 and GSTA1 are both involved in metabolic activation of several procarcinogens, and thus have been linked (in expression levels or genotypes) to the etiology of cancers such as tobacco-related lung cancer [24], colorectal cancer [25] and breast cancer [26]. Here, CYP2A6 is linked to breast cancer.